Table of Content - AI in Drug Discovery Market Size, Trends, Growth Report 2032

Artificial Intelligence in Drug Discovery Market Segmentation

Artificial Intelligence in Drug Discovery Market By Technology (USD Billion, 2019-2032)
- Machine Learning
- Natural Language Processing
- Expert Systems
- Deep Learning

Artificial Intelligence in Drug Discovery Market By Application (USD Billion, 2019-2032)
- Drug Repurposing
- Clinical Trial Patient Recruitment
- Drug Discovery
- Preclinical Research

Artificial Intelligence in Drug Discovery Market By End Use (USD Billion, 2019-2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutions
- Contract Research Organizations

Artificial Intelligence in Drug Discovery Market By Deployment Type (USD Billion, 2019-2032)
- Cloud-based
- On-premise

Artificial Intelligence in Drug Discovery Market By Regional (USD Billion, 2019-2032)
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

Artificial Intelligence in Drug Discovery Market Regional Outlook (USD Billion, 2019-2032)

North America Outlook (USD Billion, 2019-2032)
- North America Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- North America Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- North America Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- North America Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- North America Artificial Intelligence in Drug Discovery Market by Regional Type
  - US
  - Canada
- US Outlook (USD Billion, 2019-2032)
- US Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- US Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- US Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- US Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- CANADA Outlook (USD Billion, 2019-2032)
- CANADA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- CANADA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- CANADA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- CANADA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise

Europe Outlook (USD Billion, 2019-2032)
- Europe Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- Europe Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- Europe Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- Europe Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- Europe Artificial Intelligence in Drug Discovery Market by Regional Type
  - Germany
  - UK
  - France
  - Russia
  - Italy
  - Spain
  - Rest of Europe
- GERMANY Outlook (USD Billion, 2019-2032)
- GERMANY Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- GERMANY Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- GERMANY Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- GERMANY Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- UK Outlook (USD Billion, 2019-2032)
- UK Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- UK Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- UK Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- UK Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- FRANCE Outlook (USD Billion, 2019-2032)
- FRANCE Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- FRANCE Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- FRANCE Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- FRANCE Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- RUSSIA Outlook (USD Billion, 2019-2032)
- RUSSIA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- RUSSIA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- RUSSIA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- RUSSIA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- ITALY Outlook (USD Billion, 2019-2032)
- ITALY Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- ITALY Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- ITALY Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- ITALY Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- SPAIN Outlook (USD Billion, 2019-2032)
- SPAIN Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- SPAIN Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- SPAIN Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- SPAIN Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- REST OF EUROPE Outlook (USD Billion, 2019-2032)
- REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- REST OF EUROPE Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- REST OF EUROPE Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise

APAC Outlook (USD Billion, 2019-2032)
- APAC Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- APAC Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- APAC Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- APAC Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- APAC Artificial Intelligence in Drug Discovery Market by Regional Type
  - China
  - India
  - Japan
  - South Korea
  - Malaysia
  - Thailand
  - Indonesia
  - Rest of APAC
- CHINA Outlook (USD Billion, 2019-2032)
- CHINA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- CHINA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- CHINA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- CHINA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- INDIA Outlook (USD Billion, 2019-2032)
- INDIA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- INDIA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- INDIA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- INDIA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- JAPAN Outlook (USD Billion, 2019-2032)
- JAPAN Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- JAPAN Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- JAPAN Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- JAPAN Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- SOUTH KOREA Outlook (USD Billion, 2019-2032)
- SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- SOUTH KOREA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- SOUTH KOREA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- MALAYSIA Outlook (USD Billion, 2019-2032)
- MALAYSIA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- MALAYSIA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- MALAYSIA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- MALAYSIA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- THAILAND Outlook (USD Billion, 2019-2032)
- THAILAND Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- THAILAND Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- THAILAND Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- THAILAND Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- INDONESIA Outlook (USD Billion, 2019-2032)
- INDONESIA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- INDONESIA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- INDONESIA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- INDONESIA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- REST OF APAC Outlook (USD Billion, 2019-2032)
- REST OF APAC Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- REST OF APAC Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- REST OF APAC Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- REST OF APAC Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise

South America Outlook (USD Billion, 2019-2032)
- South America Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- South America Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- South America Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- South America Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- South America Artificial Intelligence in Drug Discovery Market by Regional Type
  - Brazil
  - Mexico
  - Argentina
  - Rest of South America
- BRAZIL Outlook (USD Billion, 2019-2032)
- BRAZIL Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- BRAZIL Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- BRAZIL Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- BRAZIL Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- MEXICO Outlook (USD Billion, 2019-2032)
- MEXICO Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- MEXICO Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- MEXICO Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- MEXICO Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- ARGENTINA Outlook (USD Billion, 2019-2032)
- ARGENTINA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- ARGENTINA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- ARGENTINA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- ARGENTINA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2032)
- REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- REST OF SOUTH AMERICA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise

MEA Outlook (USD Billion, 2019-2032)
- MEA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- MEA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- MEA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- MEA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- MEA Artificial Intelligence in Drug Discovery Market by Regional Type
  - GCC Countries
  - South Africa
  - Rest of MEA
- GCC COUNTRIES Outlook (USD Billion, 2019-2032)
- GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- GCC COUNTRIES Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- SOUTH AFRICA Outlook (USD Billion, 2019-2032)
- SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- SOUTH AFRICA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise
- REST OF MEA Outlook (USD Billion, 2019-2032)
- REST OF MEA Artificial Intelligence in Drug Discovery Market by Technology Type
  - Machine Learning
  - Natural Language Processing
  - Expert Systems
  - Deep Learning
- REST OF MEA Artificial Intelligence in Drug Discovery Market by Application Type
  - Drug Repurposing
  - Clinical Trial Patient Recruitment
  - Drug Discovery
  - Preclinical Research
- REST OF MEA Artificial Intelligence in Drug Discovery Market by End Use Type
  - Pharmaceutical Companies
  - Biotechnology Companies
  - Research Institutions
  - Contract Research Organizations
- REST OF MEA Artificial Intelligence in Drug Discovery Market by Deployment Type
  - Cloud-based
  - On-premise

Research Methodology on AI in Drug Discovery Market

1. Introduction

The published research report aims to explore the prospects of Artificial Intelligence (AI) in Drug Discovery and Development processes. AI has revolutionized numerous sectors, and Drug Discovery and Development is no exception. AI has the potential to make Drug Discovery and Development processes faster, more accurate and more predictable. This is the main motivation of this research to explore the valuable opportunities and challenges arising from the use of AI technologies in Drug Discovery and Development processes.

For the application of AI in Drug Discovery, the research explores two tools: Monte-Carlo Simulations and Machine Learning. Therefore, the research seeks to gain an in-depth understanding of the AI Drug Discovery and Development market and provide insights into the strategies used by the leading players.

2. Research Objectives

- To assess the rate of AI-enabled drug discovery and development activities

- To provide an in-depth analysis of the AI-driven drug discovery and development market.

- To identify the drivers and restraints that have an impact on AI-driven drug discovery and development activities.

- To predict the future of the AI-driven Drug Discovery and Development industry

- To assess the opportunities and challenges associated with AI-enabled drug discovery and development processes

- To provide insights into the strategies adopted by the leading players in the AI Drug Discovery and Development market

3. Data Sources

The primary data sources for this research are the annual reports of the leading players in the AI Drug Discovery and Development market and other related reports from various organizations, including the World Health Organization (WHO), the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) etc. Secondary data sources include published books, journals, online articles, and reports on AI Drug Discovery and Development. The data sources are selected in order to provide the most accurate and up-to-date information.

4. Research Methodologies

The research follows a qualitative approach using a combination of desk research and secondary data collection. Desk research involves the collection of data from published reports, experts, books, journals and online sources. The secondary data used in the research is further analyzed and interpreted by the experts in order to identify trends and patterns in the dataset.

The research methodology includes three main phases:

Phase 1: Identification of AI-driven drugs and drug discovery opportunities.

Phase 2: Assessing the drivers and restraints of the AI-driven Drug Discovery and Development industry.

Phase 3: Analysis of the strategies adopted by the leading players in the AI Drug Discovery and Development market.

5. Data Analysis Techniques

In order to analyze the collected data, various quantitative and qualitative data analysis techniques are used. Qualitative data analysis involves the use of Interviews and Focus Group Discussions with experts in the field of AI Drug Discovery and Development, as well as with representatives from the leading players in the market. Quantitative data analysis involves the use of SPSS software to analyse the collected data and generate insights into the trends and patterns in the dataset.

6. Validity and Reliability

The data gathered through this research is validated and cross-checked through telephone/video interviews with experts in the AI Drug Discovery and Development market and with representatives from the leading players in the industry. The data is also verified through the primary and secondary sources used in the research. This ensures the accuracy and reliability of the data and results.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY (USD BILLION)

6.1. Machine Learning

6.2. Natural Language Processing

6.3. Expert Systems

6.4. Deep Learning

7. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION (USD BILLION)

7.1. Drug Repurposing

7.2. Clinical Trial Patient Recruitment

7.3. Drug Discovery

7.4. Preclinical Research

8. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USE (USD BILLION)

8.1. Pharmaceutical Companies

8.2. Biotechnology Companies

8.3. Research Institutions

8.4. Contract Research Organizations

9. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY DEPLOYMENT TYPE (USD BILLION)

9.1. Cloud-based

9.2. On-premise

10. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Artificial Intelligence in Drug Discovery Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Artificial Intelligence in Drug Discovery Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. BristolMyers Squibb

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Siemens

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Insilico Medicine

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. Schrodinger

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Atomwise

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. BenevolentAI

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. GlaxoSmithKline

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. Oracle

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Exscientia

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. Recursion Pharmaceuticals

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Microsoft

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. IBM

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Pfizer

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. Biogen

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

12.15. Nvidia

12.15.1. Financial Overview

12.15.2. Products Offered

12.15.3. Key Developments

12.15.4. SWOT Analysis

12.15.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 3. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 4. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 5. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 6. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 7. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 8. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 9. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 10. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 11. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 12. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 13. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 14. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 15. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 16. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 17. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 18. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 19. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 20. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 21. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 22. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 23. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 24. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 25. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 26. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 27. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 28. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 29. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 30. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 31. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 32. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 33. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 34. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 35. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 36. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 37. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 38. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 39. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 40. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 41. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 42. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 43. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 44. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 45. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 46. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 47. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 48. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 49. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 50. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 51. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 52. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 53. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 54. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 55. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 56. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 57. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 58. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 59. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 60. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 61. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 62. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 64. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 65. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 66. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 68. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 69. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 70. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 71. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 72. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 73. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 74. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 76. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 77. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 78. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 79. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 80. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 81. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 82. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 83. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 84. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 85. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 86. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 87. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 88. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 89. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 90. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 91. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 92. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 93. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 94. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 95. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 96. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 97. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 98. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 99. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 100. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 101. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 102. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 103. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 104. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 105. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 106. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 107. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 108. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 109. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 110. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 111. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 112. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 113. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 114. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 115. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 116. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 117. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 118. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 119. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 120. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 121. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 127. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 128. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 129. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 130. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 131. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 132. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 133. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 134. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 135. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 136. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 137. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 138. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 139. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 140. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 141. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 142. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 143. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 144. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 145. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY DEPLOYMENT TYPE, 2019-2032 (USD BILLIONS)

TABLE 146. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

FIGURE 3. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 4. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 5. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 6. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 7. US ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 9. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 10. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 11. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 12. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

FIGURE 14. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 15. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 16. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 17. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 18. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 20. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 21. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 22. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 23. UK ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 25. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 26. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 27. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 28. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 30. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 31. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 32. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 33. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 35. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 36. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 37. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 38. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 40. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 41. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 42. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 43. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 45. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 46. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 47. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 48. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

FIGURE 50. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 51. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 52. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 53. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 54. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 56. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 57. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 58. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 59. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 61. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 62. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 63. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 64. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 66. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 67. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 68. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 69. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 71. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 72. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 73. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 74. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 76. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 77. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 78. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 79. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 81. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 82. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 83. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 84. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 86. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 87. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 88. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 89. REST OF APAC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

FIGURE 91. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 92. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 93. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 94. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 95. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 97. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 98. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 99. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 100. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 102. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 103. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 104. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 105. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 107. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 108. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 109. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 110. REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 113. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 114. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 115. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 116. GCC COUNTRIES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 118. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 119. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 120. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 121. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

FIGURE 123. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

FIGURE 124. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY END USE

FIGURE 125. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY DEPLOYMENT TYPE

FIGURE 126. REST OF MEA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET

FIGURE 133. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2024 (% SHARE)

FIGURE 134. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019 TO 2032 (USD Billions)

FIGURE 135. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2024 (% SHARE)

FIGURE 136. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)

FIGURE 137. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USE, 2024 (% SHARE)

FIGURE 138. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USE, 2019 TO 2032 (USD Billions)

FIGURE 139. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY DEPLOYMENT TYPE, 2024 (% SHARE)

FIGURE 140. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY DEPLOYMENT TYPE, 2019 TO 2032 (USD Billions)

FIGURE 141. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights